Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00758056 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2013-08-26
Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This study is looking at genetic susceptibility to cancer and interactions between genes and the environment in patients with endometrial cancer.
Conditions
Interventions
- GENETIC
-
polymorphism analysis
- OTHER
-
laboratory biomarker analysis
- OTHER
-
questionnaire administration
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Paul Pharoah, MD · Cancer Research UK
Eligibility
- Min Age
- 18 Years
- Max Age
- 74 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
Countries
- United Kingdom
Study Locations
More Related Trials
-
Estrogen, Diet, Genetics and Endometrial Cancer
NCT00587886 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
NCT01150682 ·Status: UNKNOWN
-
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
NCT00900289 ·Status: UNKNOWN
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
NCT03015376 ·Status: UNKNOWN
-
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573 ·Status: UNKNOWN
-
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
NCT01034033 ·Status: RECRUITING
-
Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique
NCT03766672 ·Status: COMPLETED
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT06893861 ·Status: RECRUITING
-
Endometrial Cancer and Array CGH
NCT02833896 ·Status: COMPLETED
-
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
NCT06564428 ·Status: RECRUITING
-
Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer
NCT05877404 ·Status: TERMINATED
-
Role of Senescence in the Development of Endometrial Cancer
NCT03338985 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers in Samples From Patients With Endometrial Cancer
NCT01199250 ·Status: WITHDRAWN
-
Targeting Inflammation for Endometrial Cancer Prevention
NCT05407025 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Testing in African Americans
NCT05591131 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
NCT06274541 ·Status: COMPLETED
-
Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer
NCT02724501 ·Status: COMPLETED
-
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
NCT02458040 ·Status: WITHDRAWN
-
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
NCT00003329 ·Status: COMPLETED
-
Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
NCT02226302 ·Status: COMPLETED
-
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
NCT01703585 ·Status: COMPLETED
-
Racial Disparity in Endometrial Cancer
NCT00375804 ·Status: TERMINATED
-
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
NCT00579163 ·Status: ACTIVE_NOT_RECRUITING